P144: TNF-inhibitor use and efficacy in upper-GI Crohn’s disease: results from a multicentre retrospective studyECCO '16 Amsterdam
2016
P145: Migraine is the most frequent extra-intestinal manifestation in patients with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P146: Risk factors of clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.ECCO '16 Amsterdam
2016
P147: The valuation of the Short Inflammatory Bowel Disease Questionnaire for use in economic evaluationsECCO '16 Amsterdam
2016
P149: Intestinal perfusion measurements with contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging enterography: A comparison studyECCO '16 Amsterdam
2016
P150: Zinc deficiency is associated with increased disease-related morbidity in Crohn’s disease patientsECCO '16 Amsterdam
2016
P151: Ulcerative colitis patients with zinc deficiency are at higher risk for disease-related complicationsECCO '16 Amsterdam
2016
P152: Faecal calprotectin 100 ug/g and 50 ug/g predict endoscopic and histologic remission: a prospective study in quiescent ulcerative colitisECCO '16 Amsterdam
2016
P153: Type of treating physician is associated with long-term disease outcome in the prospective Belgian paediatric Crohn’s disease registryECCO '16 Amsterdam
2016
P154: Temporal relationship of pregnancy to long-term disease course and pregnancy and foetal outcomes: North Indian inflammatory bowel disease cohort studyECCO '16 Amsterdam
2016
P155: Thrombophilias and thromboembolic events in a population of patients with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P156: Association between perinuclear anti-neutrophil cytoplasmic antibody status and clinical characteristics and outcomes of ulcerative colitis: a meta-analysisECCO '16 Amsterdam
2016
P157: Usefulness of, and factors influencing, the Ulcerative Colitis Endoscopic Index of Severity for the evaluation of short-term treatment responseECCO '16 Amsterdam
2016
P158: Comparison of 4L polyethylene glycol and 2L polyethylene glycol plus ascorbic acid in patients with inactive ulcerative colitis; randomised, single blind, multicentre studyECCO '16 Amsterdam
2016
P159: The utility and benefit of procalcitonin to assess disease activity and severity in Crohn’s disease and intestinal Bechet diseaseECCO '16 Amsterdam
2016
P160: Do positive psychological factors affect the perception of health-related quality of life in inflammatory bowel disease patients?ECCO '16 Amsterdam
2016
P161: Ultrasound as a primary imaging modality for follow-up of Crohn’s disease in pregnant women: initial resultsECCO '16 Amsterdam
2016